17th Aug 2020 10:40
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 14 August 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,513,192 | 1.17% | 472,043 | 0.37% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
587,000 | 0.46% | 383,659 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
2,100,192 | 1.63% | 855,702 | 0.66% | ||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 3 | 198.5700 USD |
Purchase | 8 | 199.5462 USD |
Purchase | 8 | 199.5463 USD |
Purchase | 9 | 199.5433 USD |
Purchase | 78 | 199.5000 USD |
Purchase | 100 | 200.7600 USD |
Purchase | 175 | 201.4700 USD |
Purchase | 299 | 201.3799 USD |
Purchase | 430 | 201.4736 USD |
Purchase | 500 | 201.0525 USD |
Purchase | 724 | 200.9309 USD |
Purchase | 738 | 201.3545 USD |
Purchase | 895 | 201.0836 USD |
Purchase | 1,070 | 201.2993 USD |
Purchase | 1,160 | 201.3446 USD |
Purchase | 1,616 | 201.3142 USD |
Purchase | 1,652 | 201.3410 USD |
Purchase | 1,661 | 201.0821 USD |
Purchase | 1,695 | 201.2572 USD |
Purchase | 1,895 | 201.1749 USD |
Purchase | 1,921 | 201.3185 USD |
Purchase | 2,184 | 201.5100 USD |
Purchase | 2,203 | 200.9209 USD |
Purchase | 2,595 | 200.9519 USD |
Purchase | 2,651 | 200.7225 USD |
Purchase | 3,484 | 201.3364 USD |
Purchase | 3,691 | 201.3061 USD |
Purchase | 4,057 | 201.2201 USD |
Purchase | 4,077 | 201.3137 USD |
Purchase | 21,537 | 201.2696 USD |
Purchase | 26,935 | 201.0314 USD |
Sale | 8 | 199.5462 USD |
Sale | 8 | 199.5463 USD |
Sale | 65 | 201.1443 USD |
Sale | 69 | 201.0659 USD |
Sale | 70 | 201.1343 USD |
Sale | 91 | 200.9800 USD |
Sale | 92 | 201.1635 USD |
Sale | 100 | 201.3200 USD |
Sale | 100 | 201.0700 USD |
Sale | 100 | 201.0400 USD |
Sale | 100 | 201.2200 USD |
Sale | 104 | 201.1293 USD |
Sale | 104 | 201.1700 USD |
Sale | 138 | 198.4100 USD |
Sale | 145 | 201.0043 USD |
Sale | 189 | 201.0481 USD |
Sale | 200 | 201.2500 USD |
Sale | 205 | 200.4915 USD |
Sale | 220 | 200.7763 USD |
Sale | 265 | 201.1438 USD |
Sale | 300 | 200.8250 USD |
Sale | 300 | 200.6400 USD |
Sale | 300 | 201.0933 USD |
Sale | 377 | 201.4866 USD |
Sale | 403 | 199.8636 USD |
Sale | 873 | 201.2806 USD |
Sale | 1,026 | 200.8543 USD |
Sale | 1,503 | 201.0146 USD |
Sale | 1,595 | 200.9238 USD |
Sale | 1,800 | 201.1576 USD |
Sale | 1,900 | 200.7222 USD |
Sale | 2,054 | 201.5100 USD |
Sale | 3,346 | 201.4571 USD |
Sale | 4,745 | 200.9481 USD |
Sale | 27,055 | 201.0307 USD |
Sale | 40,093 | 201.3205 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 17 Aug 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200817005241/en/
Copyright Business Wire 2020
Related Shares:
Barclays